We are three of the world’s leading medical communications companies – all underpinned by best-in-class consulting, data analytics, integrated evidence generation, and AI solutions provided by our medical excellence and transformation agency, MEDiSTRAVA.

We help medical affairs challenge convention to accelerate better outcomes.

Underpinned by the power of analytics and outcomes-focused measurement, ApotheCom is a global medical strategy agency driven by evidence, accelerating outcomes. With an extensive track record of success, our team of over 250 scientists, strategists, thinkers, designers and developers understand how to tell your scientific, clinical and values stories to better reach your audiences in this omnichannel world.

Driven by the science, we create smart solutions that deliver new standards in healthcare communications.

A family utilizing their expertise and relentless passion to share science with the world. Our illuminating approach to scientific communications is powered by our science-first ethos and integration in an effective team of our experts in medical, digital, creative, value, and patient engagement. With over 950 communications experts to form your team from, Nucleus delivers ambitious outcomes that positively impact patient care.

We make it matter by connecting science and creativity to deliver better patient impact.

Uncover a perfect balance of deep scientific knowledge and brilliant creativity to bring clarity to the complex. By creating thoughtful communications that engage, resonate and adapt to global, regional and local audiences, our team of over 830 specialists strive to support our clients to help communicate scientific breakthroughs that change lives and fundamentally reshape the future of healthcare.

We connect scientific expertise with cutting edge tech to define the strategic healthcare solutions of tomorrow.

We provide multifunctional strategic insight, communications and technical expertise to fast-track our biotech and pharma partners success. We support our partners across strategic communications and investor relations, medical and regulatory affairs, market access, HEOR and real-world evidence, and advanced medical analytics to provide a holistic view, enabling agility in planning and execution.